1. Home
  2. HYFM vs PULM Comparison

HYFM vs PULM Comparison

Compare HYFM & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hydrofarm Holdings Group Inc.

HYFM

Hydrofarm Holdings Group Inc.

N/A

Current Price

$0.81

Market Cap

4.5M

Sector

Industrials

ML Signal

N/A

Logo Pulmatrix Inc.

PULM

Pulmatrix Inc.

N/A

Current Price

$1.37

Market Cap

5.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HYFM
PULM
Founded
1977
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5M
5.2M
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
HYFM
PULM
Price
$0.81
$1.37
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 251.7K
29.7K
Earning Date
11-20-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 46.18
EPS
N/A
★ N/A
Revenue
★ $134,252,000.00
$7,910,000.00
Revenue This Year
$54.93
N/A
Revenue Next Year
$5.31
$67.27
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 5069.93
52 Week Low
$0.50
$1.06
52 Week High
$3.20
$4.98

Technical Indicators

Market Signals
Indicator
HYFM
PULM
Relative Strength Index (RSI) 50.12 47.35
Support Level $0.81 $1.23
Resistance Level $1.04 $1.46
Average True Range (ATR) 0.12 0.15
MACD 0.01 0.00
Stochastic Oscillator 57.89 62.59

Price Performance

Historical Comparison
HYFM
PULM

About HYFM Hydrofarm Holdings Group Inc.

Hydrofarm Holdings Group Inc is an independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture (CEA), including grow lights, climate control solutions, grow media, nutrients, and other products. Hydroponics involves growing plants in soilless media, often using artificial lighting in controlled indoor or greenhouse environments. Its products are used to cultivate cannabis, flowers, fruits, vegetables, grains, and herbs, enabling control over key factors such as temperature, humidity, light, nutrients, and pH. Its product portfolio spans lighting, grow media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies. The United States generates maximum revenue.

About PULM Pulmatrix Inc.

Pulmatrix Inc is a biopharmaceutical company focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

Share on Social Networks: